Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
REGULATORY
Keytruda’s Sakigake Designation Revoked after Opdivo Gastric Cancer Nod
A health ministry panel on September 28 approved the withdrawal of a sakigake fast-track designation for MSD’s anti-PD-1 antibody Keytruda (pembrolizumab) as a gastric cancer treatment after its archrival in the class, Opdivo (nivolumab), earned the nod for the indication.…
To read the full story
REGULATORY
- MOF Panel Pushes for Full Drug Price Revision in FY2027: Budget Proposal
November 20, 2026
- Mumps Shots Gain Strong Backing as Japan Weighs FY2027 NIP Priorities
November 20, 2026
- Lilly’s Oral GLP-1 Obesity Drug Heads to Dec. 2 Panel Review, Eyes Japan First
November 19, 2026
- Pharma Prods LDP to Rethink CEA Expansion, Project Team to Compile Proposal
November 19, 2026
- First Pralia Biosimilars Inching Closer to Japan Approval, 5 Products Lined Up
November 19, 2026





